Phosphorylated insulin-like growth factor-I/insulin receptor is present in all breast cancer subtypes and is related to poor survival
[DOI] [PMC free article] [PubMed] [Google Scholar] 122.Takai S., Yasumatsu K., Inoue M., Iwata S., Yoshida R., Shigemura N., Yanagawa Y., Drucker D.J., Margolskee R.F., Ninomiya Y
It is formulated specifically for individual patients who may not tolerate standard formulations or require a customized therapeutic approach
Its crucial to consult with a healthcare provider to discuss the potential benefits and risks before starting any compounded medication
If you already have a history of eye disease, your doctor may recommend additional eye exams, slower dose adjustments, or an alternative treatment altogether